首页> 外文会议>World biomaterials congress >Mixed micelles based on hyaluronic acid-poly(propylene glycol) and pluronic L61 for targeted doxorubicin delivery to multi-drug resistance MCF-7 cells
【24h】

Mixed micelles based on hyaluronic acid-poly(propylene glycol) and pluronic L61 for targeted doxorubicin delivery to multi-drug resistance MCF-7 cells

机译:基于透明质酸-聚(丙二醇)和普卢尼克L61的混合胶束,可将阿霉素靶向递送至具有多重耐药性的MCF-7细胞

获取原文

摘要

Introduction: Doxorubicin (DOX) is a widely used in chemotherapeutic anticancer drug. However, DOX showed limited anticancer effects for multi drug resistance (MDR) cancer cells, which has been considered as one of big challenges. To overcome MDR in cancer cells, diverse efflux pump inhibitors like small molecule inhibitors and polymeric inhibitors have been developed. In this study, polymeric mixed micelles incorporating Dox was designed not only to overcome MDR in cancer cells but also to deliver chemotherapeutic drug to target cancer cells. After synthesizing hyaluronic acid-poly (propylene glycol) (HP) block copolymers, HP was mixed with pluronic L61 (HPL) to fabricated mixed micelles. Physical stability, loading efficiency, and particle sizes were examined using HP and HPL micelles. The amount of intracellular uptake into MCF-7/MDR cancer cells were assessed using three types of samples including free DOX, DOX in HP, and DOX in HPL. Anticancer effects by DOX in HPL mixed micelles were also examined by cell viability assay for MCF-7/MDR cancer cells. Materials and Method: The stability of micelles was evaluated by monitoring the particle size distribution of the micelles while suspended in deionized water and kept in 37°C for 5days. To compare the amount of uptake DOX through various micelles, MCF-7/MDR cells were treated with free DOX, DOX loaded pluronic F-127, HP, HPL 3, S, 40% at a DOX concentration 2.6 μM. The cells treated with free DOX and DOX loaded various micelles were incubated for 3hr at 37°C and then the cells were incubation more 3hr after changing medium. The lysosomal membranes of the cells were disrupted by triton X-100. After centrifugation, the supernatant was measured by fluorospectrophotometer at excitation and emission 480 and 595nm. Results and Discussion: The stability of HP and HPL were evaluated by measuring their hydrodynamic diameter using a dynamic light scattering instrument. As shown in Fig1., the stability of HPL is better than HP. The aggregation of HP has been formed during 5 day, while HPL showed the better stability. To compare the amount of uptake of DOX, free DOX, DOX in micelles were treated to MDR cancer cells. As shown in Fig 2, while the amount of uptake of free DOX was negligible, the amount of DOX in micelles in cancer cells was greatly higher than free DOX. In the case of comparing various micelles, the DOX in HPL 3% was shown the most amount of uptake. Conclusions: In this study, HP graft copolymer was synthesized and characterized. HPL mixed micelles showed greatly improved particle stability and loading efficiency of DOX, compared to HP micelles. In addition, DOX in HPL was much more successfully internalized into MCF-7/MDR cells than free DOX. Therefore, HPL mixed micelles can serve as a nanocarrier for targeted chemotherapeutics for MDR cancer cells.
机译:简介:阿霉素(DOX)是一种广泛用于化学治疗的抗癌药物。但是,DOX对多药耐药性(MDR)癌细胞的抗癌作用有限,这被认为是一大挑战。为了克服癌细胞中的MDR,已经开发了多种外排泵抑制剂,例如小分子抑制剂和聚合物抑制剂。在这项研究中,掺有Dox的聚合物混合胶束不仅可以克服癌细胞中的MDR,而且可以将化学治疗药物递送至靶癌细胞。合成透明质酸-聚(丙二醇)(HP)嵌段共聚物后,将HP与pluronic L61(HPL)混合,制成混合胶束。使用HP和HPL胶束检查了物理稳定性,负载效率和粒径。使用三种类型的样品,包括游离DOX,HP中的DOX和HPL中的DOX,评估了MCF-7 / MDR癌细胞的细胞内摄取量。还通过MCF-7 / MDR癌细胞的细胞生存力分析检查了DOX在HPL混合胶束中的抗癌作用。材料和方法:胶束的稳定性是通过监测胶束悬浮在去离子水中并在37°C保持5天的粒径分布来评估的。为了比较通过各种胶束摄取DOX的量,将MCF-7 / MDR细胞用游离DOX,负载DOX的普鲁尼克F-127,HP,HPL 3,S,40%,DOX浓度为2.6μM处理。用游离DOX和负载DOX的各种胶束处理的细胞在37℃下孵育3小时,然后在更换培养基后再孵育3小时。 Triton X-100破坏了细胞的溶酶体膜。离心后,通过荧光分光光度计在480nm和595nm的激发和发射下测量上清液。结果与讨论:HP和HPL的稳定性是通过使用动态光散射仪测量其流体动力学直径来评估的。如图1所示,HPL的稳定性优于HP。 HP的聚集在5天之内形成,而HPL显示出更好的稳定性。为了比较DOX的摄取量,将胶束中的游离DOX,DOX处理成MDR癌细胞。如图2所示,尽管游离DOX的摄取量可以忽略不计,但癌细胞胶束中的DOX量却大大高于游离DOX。在比较各种胶束的情况下,HPL 3%中的DOX表现出最大的摄取量。结论:本研究合成并表征了HP接枝共聚物。与HP胶束相比,HPL混合胶束显示出大大提高的DOX颗粒稳定性和负载效率。此外,HPL中的DOX比游离DOX更成功地内化到MCF-7 / MDR细胞中。因此,HPL混合胶束可作为纳米载体,用于MDR癌细胞的靶向化学治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号